Hereditary Transthyretin Amyloidosis (HATTR) Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Hereditary Transthyretin Amyloidosis (HATTR) in Global, including the following market information:
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hereditary Transthyretin Amyloidosis (HATTR) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hereditary Transthyretin Amyloidosis (HATTR) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Transthyretin Amyloidosis (HATTR) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, By Type, 2020 (%)
China Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, By Application, 2020 (%)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Total Hereditary Transthyretin Amyloidosis (HATTR) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hereditary Transthyretin Amyloidosis (HATTR) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hereditary Transthyretin Amyloidosis (HATTR) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hereditary Transthyretin Amyloidosis (HATTR) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Transthyretin Amyloidosis (HATTR) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, By Type, 2020 (%)
- Oral
- Subcutaneous Injection
- Others
China Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, By Application, 2020 (%)
- Hospital
- Clinic
- Others
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Total Hereditary Transthyretin Amyloidosis (HATTR) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hereditary Transthyretin Amyloidosis (HATTR) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Pfizer
- Alnylam Pharmaceuticals
- Akcea Therapeutics
- Prothena
- Lonis Pharmaceuticals
- Eidos Therapeutics
- Corino Therapeutics Inc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Insulin Pumps and Accessories Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insulin Pumps and Accessories Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INSULIN PUMPS AND ACCESSORIES OVERALL MARKET SIZE
2.1 Global Insulin Pumps and Accessories Market Size: 2021 VS 2027
2.2 Global Insulin Pumps and Accessories Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Insulin Pumps and Accessories Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Insulin Pumps and Accessories Players in Global Market
3.2 Top Global Insulin Pumps and Accessories Companies Ranked by Revenue
3.3 Global Insulin Pumps and Accessories Revenue by Companies
3.4 Global Insulin Pumps and Accessories Sales by Companies
3.5 Global Insulin Pumps and Accessories Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Insulin Pumps and Accessories Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Insulin Pumps and Accessories Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Pumps and Accessories Players in Global Market
3.8.1 List of Global Tier 1 Insulin Pumps and Accessories Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin Pumps and Accessories Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Insulin Pumps and Accessories Market Size Markets, 2021 & 2027
4.1.2 Tethered Insulin Pump
4.1.3 Patch Insulin Pump
4.1.4 Consumables
4.2 By Type - Global Insulin Pumps and Accessories Revenue & Forecasts
4.2.1 By Type - Global Insulin Pumps and Accessories Revenue, 2016-2021
4.2.2 By Type - Global Insulin Pumps and Accessories Revenue, 2022-2027
4.2.3 By Type - Global Insulin Pumps and Accessories Revenue Market Share, 2016-2027
4.3 By Type - Global Insulin Pumps and Accessories Sales & Forecasts
4.3.1 By Type - Global Insulin Pumps and Accessories Sales, 2016-2021
4.3.2 By Type - Global Insulin Pumps and Accessories Sales, 2022-2027
4.3.3 By Type - Global Insulin Pumps and Accessories Sales Market Share, 2016-2027
4.4 By Type - Global Insulin Pumps and Accessories Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Insulin Pumps and Accessories Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Home Healthcare
5.1.5 Others
5.2 By Application - Global Insulin Pumps and Accessories Revenue & Forecasts
5.2.1 By Application - Global Insulin Pumps and Accessories Revenue, 2016-2021
5.2.2 By Application - Global Insulin Pumps and Accessories Revenue, 2022-2027
5.2.3 By Application - Global Insulin Pumps and Accessories Revenue Market Share, 2016-2027
5.3 By Application - Global Insulin Pumps and Accessories Sales & Forecasts
5.3.1 By Application - Global Insulin Pumps and Accessories Sales, 2016-2021
5.3.2 By Application - Global Insulin Pumps and Accessories Sales, 2022-2027
5.3.3 By Application - Global Insulin Pumps and Accessories Sales Market Share, 2016-2027
5.4 By Application - Global Insulin Pumps and Accessories Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Insulin Pumps and Accessories Market Size, 2021 & 2027
6.2 By Region - Global Insulin Pumps and Accessories Revenue & Forecasts
6.2.1 By Region - Global Insulin Pumps and Accessories Revenue, 2016-2021
6.2.2 By Region - Global Insulin Pumps and Accessories Revenue, 2022-2027
6.2.3 By Region - Global Insulin Pumps and Accessories Revenue Market Share, 2016-2027
6.3 By Region - Global Insulin Pumps and Accessories Sales & Forecasts
6.3.1 By Region - Global Insulin Pumps and Accessories Sales, 2016-2021
6.3.2 By Region - Global Insulin Pumps and Accessories Sales, 2022-2027
6.3.3 By Region - Global Insulin Pumps and Accessories Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Insulin Pumps and Accessories Revenue, 2016-2027
6.4.2 By Country - North America Insulin Pumps and Accessories Sales, 2016-2027
6.4.3 US Insulin Pumps and Accessories Market Size, 2016-2027
6.4.4 Canada Insulin Pumps and Accessories Market Size, 2016-2027
6.4.5 Mexico Insulin Pumps and Accessories Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Insulin Pumps and Accessories Revenue, 2016-2027
6.5.2 By Country - Europe Insulin Pumps and Accessories Sales, 2016-2027
6.5.3 Germany Insulin Pumps and Accessories Market Size, 2016-2027
6.5.4 France Insulin Pumps and Accessories Market Size, 2016-2027
6.5.5 U.K. Insulin Pumps and Accessories Market Size, 2016-2027
6.5.6 Italy Insulin Pumps and Accessories Market Size, 2016-2027
6.5.7 Russia Insulin Pumps and Accessories Market Size, 2016-2027
6.5.8 Nordic Countries Insulin Pumps and Accessories Market Size, 2016-2027
6.5.9 Benelux Insulin Pumps and Accessories Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Insulin Pumps and Accessories Revenue, 2016-2027
6.6.2 By Region - Asia Insulin Pumps and Accessories Sales, 2016-2027
6.6.3 China Insulin Pumps and Accessories Market Size, 2016-2027
6.6.4 Japan Insulin Pumps and Accessories Market Size, 2016-2027
6.6.5 South Korea Insulin Pumps and Accessories Market Size, 2016-2027
6.6.6 Southeast Asia Insulin Pumps and Accessories Market Size, 2016-2027
6.6.7 India Insulin Pumps and Accessories Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Insulin Pumps and Accessories Revenue, 2016-2027
6.7.2 By Country - South America Insulin Pumps and Accessories Sales, 2016-2027
6.7.3 Brazil Insulin Pumps and Accessories Market Size, 2016-2027
6.7.4 Argentina Insulin Pumps and Accessories Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insulin Pumps and Accessories Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Insulin Pumps and Accessories Sales, 2016-2027
6.8.3 Turkey Insulin Pumps and Accessories Market Size, 2016-2027
6.8.4 Israel Insulin Pumps and Accessories Market Size, 2016-2027
6.8.5 Saudi Arabia Insulin Pumps and Accessories Market Size, 2016-2027
6.8.6 UAE Insulin Pumps and Accessories Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Debiotech S.A.
7.1.1 Debiotech S.A. Corporate Summary
7.1.2 Debiotech S.A. Business Overview
7.1.3 Debiotech S.A. Insulin Pumps and Accessories Major Product Offerings
7.1.4 Debiotech S.A. Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.1.5 Debiotech S.A. Key News
7.2 Diabeloop S.A.
7.2.1 Diabeloop S.A. Corporate Summary
7.2.2 Diabeloop S.A. Business Overview
7.2.3 Diabeloop S.A. Insulin Pumps and Accessories Major Product Offerings
7.2.4 Diabeloop S.A. Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.2.5 Diabeloop S.A. Key News
7.3 F. Hoffmann-La Roche Ag
7.3.1 F. Hoffmann-La Roche Ag Corporate Summary
7.3.2 F. Hoffmann-La Roche Ag Business Overview
7.3.3 F. Hoffmann-La Roche Ag Insulin Pumps and Accessories Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ag Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.3.5 F. Hoffmann-La Roche Ag Key News
7.4 Insulet Corporation
7.4.1 Insulet Corporation Corporate Summary
7.4.2 Insulet Corporation Business Overview
7.4.3 Insulet Corporation Insulin Pumps and Accessories Major Product Offerings
7.4.4 Insulet Corporation Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.4.5 Insulet Corporation Key News
7.5 Medtronic Plc
7.5.1 Medtronic Plc Corporate Summary
7.5.2 Medtronic Plc Business Overview
7.5.3 Medtronic Plc Insulin Pumps and Accessories Major Product Offerings
7.5.4 Medtronic Plc Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.5.5 Medtronic Plc Key News
7.6 Microport Scientific Corporation
7.6.1 Microport Scientific Corporation Corporate Summary
7.6.2 Microport Scientific Corporation Business Overview
7.6.3 Microport Scientific Corporation Insulin Pumps and Accessories Major Product Offerings
7.6.4 Microport Scientific Corporation Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.6.5 Microport Scientific Corporation Key News
7.7 Sooil Development Co
7.7.1 Sooil Development Co Corporate Summary
7.7.2 Sooil Development Co Business Overview
7.7.3 Sooil Development Co Insulin Pumps and Accessories Major Product Offerings
7.4.4 Sooil Development Co Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.7.5 Sooil Development Co Key News
7.8 Tandem Diabetes Care Inc
7.8.1 Tandem Diabetes Care Inc Corporate Summary
7.8.2 Tandem Diabetes Care Inc Business Overview
7.8.3 Tandem Diabetes Care Inc Insulin Pumps and Accessories Major Product Offerings
7.8.4 Tandem Diabetes Care Inc Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.8.5 Tandem Diabetes Care Inc Key News
7.9 Valeritas Holdings Inc
7.9.1 Valeritas Holdings Inc Corporate Summary
7.9.2 Valeritas Holdings Inc Business Overview
7.9.3 Valeritas Holdings Inc Insulin Pumps and Accessories Major Product Offerings
7.9.4 Valeritas Holdings Inc Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.9.5 Valeritas Holdings Inc Key News
7.10 Ypsomed Holding Ag
7.10.1 Ypsomed Holding Ag Corporate Summary
7.10.2 Ypsomed Holding Ag Business Overview
7.10.3 Ypsomed Holding Ag Insulin Pumps and Accessories Major Product Offerings
7.10.4 Ypsomed Holding Ag Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.10.5 Ypsomed Holding Ag Key News
8 GLOBAL INSULIN PUMPS AND ACCESSORIES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Insulin Pumps and Accessories Production Capacity, 2016-2027
8.2 Insulin Pumps and Accessories Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Pumps and Accessories Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INSULIN PUMPS AND ACCESSORIES SUPPLY CHAIN ANALYSIS
10.1 Insulin Pumps and Accessories Industry Value Chain
10.2 Insulin Pumps and Accessories Upstream Market
10.3 Insulin Pumps and Accessories Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin Pumps and Accessories Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Insulin Pumps and Accessories Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insulin Pumps and Accessories Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INSULIN PUMPS AND ACCESSORIES OVERALL MARKET SIZE
2.1 Global Insulin Pumps and Accessories Market Size: 2021 VS 2027
2.2 Global Insulin Pumps and Accessories Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Insulin Pumps and Accessories Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Insulin Pumps and Accessories Players in Global Market
3.2 Top Global Insulin Pumps and Accessories Companies Ranked by Revenue
3.3 Global Insulin Pumps and Accessories Revenue by Companies
3.4 Global Insulin Pumps and Accessories Sales by Companies
3.5 Global Insulin Pumps and Accessories Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Insulin Pumps and Accessories Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Insulin Pumps and Accessories Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Pumps and Accessories Players in Global Market
3.8.1 List of Global Tier 1 Insulin Pumps and Accessories Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin Pumps and Accessories Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Insulin Pumps and Accessories Market Size Markets, 2021 & 2027
4.1.2 Tethered Insulin Pump
4.1.3 Patch Insulin Pump
4.1.4 Consumables
4.2 By Type - Global Insulin Pumps and Accessories Revenue & Forecasts
4.2.1 By Type - Global Insulin Pumps and Accessories Revenue, 2016-2021
4.2.2 By Type - Global Insulin Pumps and Accessories Revenue, 2022-2027
4.2.3 By Type - Global Insulin Pumps and Accessories Revenue Market Share, 2016-2027
4.3 By Type - Global Insulin Pumps and Accessories Sales & Forecasts
4.3.1 By Type - Global Insulin Pumps and Accessories Sales, 2016-2021
4.3.2 By Type - Global Insulin Pumps and Accessories Sales, 2022-2027
4.3.3 By Type - Global Insulin Pumps and Accessories Sales Market Share, 2016-2027
4.4 By Type - Global Insulin Pumps and Accessories Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Insulin Pumps and Accessories Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Home Healthcare
5.1.5 Others
5.2 By Application - Global Insulin Pumps and Accessories Revenue & Forecasts
5.2.1 By Application - Global Insulin Pumps and Accessories Revenue, 2016-2021
5.2.2 By Application - Global Insulin Pumps and Accessories Revenue, 2022-2027
5.2.3 By Application - Global Insulin Pumps and Accessories Revenue Market Share, 2016-2027
5.3 By Application - Global Insulin Pumps and Accessories Sales & Forecasts
5.3.1 By Application - Global Insulin Pumps and Accessories Sales, 2016-2021
5.3.2 By Application - Global Insulin Pumps and Accessories Sales, 2022-2027
5.3.3 By Application - Global Insulin Pumps and Accessories Sales Market Share, 2016-2027
5.4 By Application - Global Insulin Pumps and Accessories Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Insulin Pumps and Accessories Market Size, 2021 & 2027
6.2 By Region - Global Insulin Pumps and Accessories Revenue & Forecasts
6.2.1 By Region - Global Insulin Pumps and Accessories Revenue, 2016-2021
6.2.2 By Region - Global Insulin Pumps and Accessories Revenue, 2022-2027
6.2.3 By Region - Global Insulin Pumps and Accessories Revenue Market Share, 2016-2027
6.3 By Region - Global Insulin Pumps and Accessories Sales & Forecasts
6.3.1 By Region - Global Insulin Pumps and Accessories Sales, 2016-2021
6.3.2 By Region - Global Insulin Pumps and Accessories Sales, 2022-2027
6.3.3 By Region - Global Insulin Pumps and Accessories Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Insulin Pumps and Accessories Revenue, 2016-2027
6.4.2 By Country - North America Insulin Pumps and Accessories Sales, 2016-2027
6.4.3 US Insulin Pumps and Accessories Market Size, 2016-2027
6.4.4 Canada Insulin Pumps and Accessories Market Size, 2016-2027
6.4.5 Mexico Insulin Pumps and Accessories Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Insulin Pumps and Accessories Revenue, 2016-2027
6.5.2 By Country - Europe Insulin Pumps and Accessories Sales, 2016-2027
6.5.3 Germany Insulin Pumps and Accessories Market Size, 2016-2027
6.5.4 France Insulin Pumps and Accessories Market Size, 2016-2027
6.5.5 U.K. Insulin Pumps and Accessories Market Size, 2016-2027
6.5.6 Italy Insulin Pumps and Accessories Market Size, 2016-2027
6.5.7 Russia Insulin Pumps and Accessories Market Size, 2016-2027
6.5.8 Nordic Countries Insulin Pumps and Accessories Market Size, 2016-2027
6.5.9 Benelux Insulin Pumps and Accessories Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Insulin Pumps and Accessories Revenue, 2016-2027
6.6.2 By Region - Asia Insulin Pumps and Accessories Sales, 2016-2027
6.6.3 China Insulin Pumps and Accessories Market Size, 2016-2027
6.6.4 Japan Insulin Pumps and Accessories Market Size, 2016-2027
6.6.5 South Korea Insulin Pumps and Accessories Market Size, 2016-2027
6.6.6 Southeast Asia Insulin Pumps and Accessories Market Size, 2016-2027
6.6.7 India Insulin Pumps and Accessories Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Insulin Pumps and Accessories Revenue, 2016-2027
6.7.2 By Country - South America Insulin Pumps and Accessories Sales, 2016-2027
6.7.3 Brazil Insulin Pumps and Accessories Market Size, 2016-2027
6.7.4 Argentina Insulin Pumps and Accessories Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insulin Pumps and Accessories Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Insulin Pumps and Accessories Sales, 2016-2027
6.8.3 Turkey Insulin Pumps and Accessories Market Size, 2016-2027
6.8.4 Israel Insulin Pumps and Accessories Market Size, 2016-2027
6.8.5 Saudi Arabia Insulin Pumps and Accessories Market Size, 2016-2027
6.8.6 UAE Insulin Pumps and Accessories Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Debiotech S.A.
7.1.1 Debiotech S.A. Corporate Summary
7.1.2 Debiotech S.A. Business Overview
7.1.3 Debiotech S.A. Insulin Pumps and Accessories Major Product Offerings
7.1.4 Debiotech S.A. Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.1.5 Debiotech S.A. Key News
7.2 Diabeloop S.A.
7.2.1 Diabeloop S.A. Corporate Summary
7.2.2 Diabeloop S.A. Business Overview
7.2.3 Diabeloop S.A. Insulin Pumps and Accessories Major Product Offerings
7.2.4 Diabeloop S.A. Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.2.5 Diabeloop S.A. Key News
7.3 F. Hoffmann-La Roche Ag
7.3.1 F. Hoffmann-La Roche Ag Corporate Summary
7.3.2 F. Hoffmann-La Roche Ag Business Overview
7.3.3 F. Hoffmann-La Roche Ag Insulin Pumps and Accessories Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ag Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.3.5 F. Hoffmann-La Roche Ag Key News
7.4 Insulet Corporation
7.4.1 Insulet Corporation Corporate Summary
7.4.2 Insulet Corporation Business Overview
7.4.3 Insulet Corporation Insulin Pumps and Accessories Major Product Offerings
7.4.4 Insulet Corporation Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.4.5 Insulet Corporation Key News
7.5 Medtronic Plc
7.5.1 Medtronic Plc Corporate Summary
7.5.2 Medtronic Plc Business Overview
7.5.3 Medtronic Plc Insulin Pumps and Accessories Major Product Offerings
7.5.4 Medtronic Plc Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.5.5 Medtronic Plc Key News
7.6 Microport Scientific Corporation
7.6.1 Microport Scientific Corporation Corporate Summary
7.6.2 Microport Scientific Corporation Business Overview
7.6.3 Microport Scientific Corporation Insulin Pumps and Accessories Major Product Offerings
7.6.4 Microport Scientific Corporation Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.6.5 Microport Scientific Corporation Key News
7.7 Sooil Development Co
7.7.1 Sooil Development Co Corporate Summary
7.7.2 Sooil Development Co Business Overview
7.7.3 Sooil Development Co Insulin Pumps and Accessories Major Product Offerings
7.4.4 Sooil Development Co Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.7.5 Sooil Development Co Key News
7.8 Tandem Diabetes Care Inc
7.8.1 Tandem Diabetes Care Inc Corporate Summary
7.8.2 Tandem Diabetes Care Inc Business Overview
7.8.3 Tandem Diabetes Care Inc Insulin Pumps and Accessories Major Product Offerings
7.8.4 Tandem Diabetes Care Inc Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.8.5 Tandem Diabetes Care Inc Key News
7.9 Valeritas Holdings Inc
7.9.1 Valeritas Holdings Inc Corporate Summary
7.9.2 Valeritas Holdings Inc Business Overview
7.9.3 Valeritas Holdings Inc Insulin Pumps and Accessories Major Product Offerings
7.9.4 Valeritas Holdings Inc Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.9.5 Valeritas Holdings Inc Key News
7.10 Ypsomed Holding Ag
7.10.1 Ypsomed Holding Ag Corporate Summary
7.10.2 Ypsomed Holding Ag Business Overview
7.10.3 Ypsomed Holding Ag Insulin Pumps and Accessories Major Product Offerings
7.10.4 Ypsomed Holding Ag Insulin Pumps and Accessories Sales and Revenue in Global (2016-2021)
7.10.5 Ypsomed Holding Ag Key News
8 GLOBAL INSULIN PUMPS AND ACCESSORIES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Insulin Pumps and Accessories Production Capacity, 2016-2027
8.2 Insulin Pumps and Accessories Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Pumps and Accessories Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INSULIN PUMPS AND ACCESSORIES SUPPLY CHAIN ANALYSIS
10.1 Insulin Pumps and Accessories Industry Value Chain
10.2 Insulin Pumps and Accessories Upstream Market
10.3 Insulin Pumps and Accessories Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin Pumps and Accessories Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Hereditary Transthyretin Amyloidosis (HATTR) Market Opportunities & Trends in Global Market
Table 2. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers in Global Market
Table 3. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints in Global Market
Table 4. Key Players of Hereditary Transthyretin Amyloidosis (HATTR) in Global Market
Table 5. Top Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hereditary Transthyretin Amyloidosis (HATTR) Product Type
Table 9. List of Global Tier 1 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 32. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 33. Alnylam Pharmaceuticals Corporate Summary
Table 34. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 35. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 36. Akcea Therapeutics Corporate Summary
Table 37. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 38. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 39. Prothena Corporate Summary
Table 40. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 41. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 42. Lonis Pharmaceuticals Corporate Summary
Table 43. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 44. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 45. Eidos Therapeutics Corporate Summary
Table 46. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 47. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 48. Corino Therapeutics Inc Corporate Summary
Table 49. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 50. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 1. Hereditary Transthyretin Amyloidosis (HATTR) Market Opportunities & Trends in Global Market
Table 2. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers in Global Market
Table 3. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints in Global Market
Table 4. Key Players of Hereditary Transthyretin Amyloidosis (HATTR) in Global Market
Table 5. Top Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hereditary Transthyretin Amyloidosis (HATTR) Product Type
Table 9. List of Global Tier 1 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 32. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 33. Alnylam Pharmaceuticals Corporate Summary
Table 34. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 35. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 36. Akcea Therapeutics Corporate Summary
Table 37. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 38. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 39. Prothena Corporate Summary
Table 40. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 41. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 42. Lonis Pharmaceuticals Corporate Summary
Table 43. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 44. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 45. Eidos Therapeutics Corporate Summary
Table 46. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 47. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
Table 48. Corino Therapeutics Inc Corporate Summary
Table 49. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 50. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2016-2021)
LIST OF FIGURES
Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Type
Figure 2. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Application
Figure 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2020
Figure 8. By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 12. US Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 16. Germany Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 17. France Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 24. China Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 28. India Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 30. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 33. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Type
Figure 2. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Application
Figure 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2020
Figure 8. By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 12. US Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 16. Germany Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 17. France Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 24. China Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 28. India Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 30. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2016-2027
Figure 33. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
